Help Children with Cancer Access Treatment!

by Advita Fund USA
Help Children with Cancer Access Treatment!
Nov 6, 2020

Immunotherapy for Rostislav

Rostislav
Rostislav

2020 has been such a turbulent year that it's safe to say that all of us are feeling its effects to some degree.  The uncertainty over our future, fears of catching a deadly virus, worries about our loved ones and rapidly changing circumstances have been our companions for many months.  And so much unknown still lies ahead.

These emotions are not unlike experiences that families of children with cancer go through from the moment of diagnosis.  It's a heavy burden of emotional, physical and financial turmoil, and to cope with it the families have to mobilize all of their resources and reach out to wide and far communities.  Often, in search of appropriate treatment their journey takes them abroad.  Rostislav's family had to follow just such a path. 

Rostislav is now 3 years old. He's been growing up healthy and happy and enjoyed going to daycare. A month ago he suddenly began complaining of stomachaches, and his parents took him to see a doctor. A large abdominal tumor was discovered by Rostislav’s local doctors in the city of Khmelnitskyi, in western Ukraine, and he was referred for additional evaluation in Kyiv. There Rostislav was diagnosed with aggressive childhood cancer, neuroblastoma. Unfortunately, the primary tumor metastasized to Rostislav’s bone marrow by that time. Neuroblastoma’s treatment is highly complex and challenging and requires several approaches that have to precisely timed – surgery, chemotherapy, radiation and immunotherapy. Immunotherapy, which cuts the risk of relapse by half, is only available abroad, and Rostislav’s parents took him to Spain to access this treatment. While they were able to raise money for initial deposit, they will need to raise much more to be able to complete treatment.

Our project helps to support families like Rostislav's.  We believe that every child regardless of their place of birth deserves access to the best care available for cancer.  We search the world for the proper opportunities or support patients that have already found treatment on their own but need financial aid. Thank you so much for allowing us to continue our work!

We are truly grateful for your help!  Hope the upcoming holiday season will bring you joy and happiness.

Stay safe!

Share on Twitter Share on Facebook
Comments:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Organization Information

Advita Fund USA

Location: Houston, Texas - USA
Website:
Facebook: Facebook Page
Twitter: @advitausa
Project Leader:
Marina Ouano
President
Houston, Texas United States
$61,812 raised of $80,000 goal
 
823 donations
$18,188 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

Advita Fund USA has earned this recognition on GlobalGiving:
Add Project to Favorites

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.